Depomed reported $35.13M in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Aerie Pharmaceuticals AERI:US $ 33.31M 3.48M
Ani Pharmaceuticals ANIP:US $ 73.86M 9.38M
Aurora Cannabis Inc ACB:CN 50.43M 10.15M
Cara Therapeutics CARA:US $ 23M 18.21M
Daiichi Sankyo 4568:JP Y 280317M 46392M
Depomed DEPO:US $ 35.13M 1.41M
Ironwood Pharmaceuticals IRWD:US $ 97.23M 0.3M
Johnson & Johnson JNJ:US $ 24020M 594M
Knight Therapeutics Inc GUD:CN C$ 75.82M 12.01M
Merk MRK:US $ 14593M 1308M
Nektar Therapeutics NKTR:US $ 21.58M 3.24M
Pfizer PFE:US $ 27742M 2081M
Teva Pharmaceutical TEVA:IT 3.79B 125M